The Infectious Diseases Institute (IDI) is a Ugandan not-for-profit organization whose mission is to strengthen health systems in Africa, with strong emphasis on infectious diseases, through research and capacity development. IDI has six operational areas through which it works to achieve its mission: Prevention, Care and Treatment; Training, Research, Laboratory services (including the CAP-certified IDI Core Lab & Translational Lab), Global Health Security and Health System Strengthening.
Students intending to pursue their internships with IDI and volunteers should submit their applications through this HR online application Portal.
Please follow the link to register for Internship or Volunteering, or login.
The Locum Study Midwife will support implementation of the Maternal Ultrasound Observational Study for Machine Learning Model Training study (AI US Scan study) being implemented at Kawempe National Referral Hospital. She will work together with the study team at the hospital to screen, obtain informed consent, enrol participants and conduct study procedures, in order to meet the study recruitment targets. The Locum Study midwife will ensure high level confidentiality and adherence to international and national GCP guidelines whilst providing care to the study participants.
The Locum Study Midwife will support implementation of the Maternal Ultrasound Observational Study for Machine Learning Model Training study (AI US Scan study) being implemented at Kawempe National Referral Hospital. She will work together with the study team at the hospital to screen, obtain informed consent, enrol participants and conduct study procedures, in order to meet the study recruitment targets. The Locum Study midwife will ensure high level confidentiality and adherence to international and national GCP guidelines whilst providing care to the study participants.
MK-8527-010 project is “A Phase 3, Randomized, Active-controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 as HIV-1 Preexposure Prophylaxis in Cisgender Women”.
MK-8527-010 project is “A Phase 3, Randomized, Active-controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 as HIV-1 Preexposure Prophylaxis in Cisgender Women”.